Clinical Trial Update: ACTH in Progressive Forms of MS [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating adrenocorticotropic hormone (ACTH) for progressive forms of multiple sclerosis has been terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• adrenocorticotropic hormone (ACTH) (adrenocorticotropic hormone)

Snippet

Sponsor: University of Minnesota | Conditions: Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis | Phase 2 | Status: TERMINATED | Results posted: 2025-02-11